OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 03, 2022
Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.
Bacteriophages could be crucial weapons in the fight against antibiotic-resistant bacteria.
March 01, 2022
BioMed X and Boehringer Ingelheim have announced the start of a new research project in brain sensor development.
February 03, 2022
In this study, researchers evaluated the colloidal microcrystalline cellulose (cMCC) suspending agent—a co-processed material of microcrystalline cellulose and sodium carboxymethyl cellulose (NaCMC)—by using a representative pharmaceutical-grade commercial version of cMCC.
February 01, 2022
A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.
January 03, 2022
Dosage form and patient needs drive excipient choice.
Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.
December 03, 2021
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
November 03, 2021
Investing in formulation strategies earlier on in development will maximize the chance of success.
Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.